Clinical Trial

A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants

Study acronym: HV
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 21, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase 1 Clinical Study Of BW-20805-2-1001 in Healthy Participants
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-07.
Trial Details
NCT Number NCT07528053
Lead Sponsor Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions HV
Enrollment 24 participants
Start Date 2026-04-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-11-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-21